poisar

Stocks · News reference

Kazia Therapeutics to Host Virtual Event on NDL2 Program

Fiscal.ai

Kazia Therapeutics announced it will host a virtual event on December 2, 2026, to provide a management overview of its NDL2 program, a novel nuclear PD-L1 protein degrader.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading